Innlanz Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INL.AX research report →
Price Chart
About the company
Based in Parramatta, Australia, Innlanz Limited oversees and possesses a hotel located in Hamilton, New Zealand. This entity, established in 2002, transitioned to its present name in November 2021, having previously been known as Mediland Pharm Limited. It operates as a subsidiary of Pacific Merchants Group Limited.
- CEO
- Yeshween Mudaliar
- IPO
- 2019
- HQ
- Parramatta, NSW, AU
Get TickerSpark's AI analysis on INL.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.82M
- P/E
- -10.00
- PEG
- 0.16
- P/S
- 1.07
- P/B
- 1.03
- EV/EBITDA
- -64.46
- Div Yield
- 0.00%
- Gross Margin
- 97.86%
- Op Margin
- -7.13%
- Net Margin
- -10.72%
- ROE
- -10.02%
- ROIC
- -2.83%
Latest fiscal year · YoY change
- Revenue
- $2.64M+65.7%
- Gross Profit
- $2.58M+65.4%
- Op Income
- $-188,364
- Net Income
- $-283,143+68.9%
- EPS
- $-0.00+69.0%
- OCF Growth
- +91.9%
- FCF Growth
- +86.2%
- 52W High
- $0.03
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.50
- RSI (14)
- 4
- Avg Volume
- 1.31K
No earnings-call transcripts are available for INL.AX yet.
- Free Float
- 2.9%
- Shares Outstanding
- 313.26M
- Float Shares
- 9.08M
Our INL.AX coverage
Recent articles, reports, and earnings notes.
No research on INL.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate INL.AX report →